Two earlier trials demonstrated that a vaccine based on the HSV-2 glycoprotein D subunit (gD-2) was effective in protecting HSV-1/HSV-2-seronegative women whose sexual partners had recurrent HSV ...

Get discount on Purchase report @ Questions Answered by the Report: (1) Which are the dominant players of the Herpes Simplex Virus (Hsv) Vaccines Market? (2) What will be the size of the Herpes ...

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.

Twenty percent of under-50s worldwide are infected with genital herpes, with 42 million new cases being recorded in 2020 alone.

The global genital herpes treatment market is expected to grow at a CAGR of 5.2% from 2023 to 2033. Market valuation will ...

HSV-1 is primarily spread in childhood by mouth ... They add: “There is a need for HSV prophylactic and therapeutic vaccines as a strategic approach to control transmission and to curb the ...

A BRIN researcher has suggested that the influenza vaccine could be an option to prevent the spread of the Human ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Genital herpes is caused by two types of herpes simplex virus (HSV) – HSV-1 and HSV-2 ... research and investment in developing new herpes vaccines and therapies, and their equitable use ...

(HealthDay News) — The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are ... HSV prophylactic and therapeutic vaccines as a strategic approach to control ...